对不吸入糖皮质激素的患者来说，规律使用沙美特罗与规律使用沙丁胺醇相比，其致死性及非致死性严重不良事件的发生率并无显著增加。
Compared with regular salbutamol, regular salmeterol was not associated with a significant increase in fatal or nonfatal serious adverse events in patients not taking inhaled corticosteroids.
偏侧卒中并不是心血管不良事件和90天死亡率的重要预测指标。
Stroke lateralization is not an important predictor of cardiac adverse events or 90-day mortality.
目的：调查住院病人药物不良事件（ADE）发生率、因ADE而造成的医疗费用、延长的住院时间及ADE的可防范率。
Objective:To assess existence and preventability of adverse drug events(ADEs) and to investigate excess length of stay and extra hospital charges of the ADEs.
重访率或不良事件无显著差异，虽然在五个恩丹西酮的研究报告中，有四个研究报告显示有腹泻的副作用。
No significant difference was noted in the revisit rates or adverse events, although diarrhea was reported as a side effect in four of the five ondansetron studies.
两组观察中无严重不良事件。两组间事件的发生率相似。
No severe adverse events were observed in either group. The frequency of events was generally similar between the two groups.
严重不良事件的发生率(3%)，与安慰剂相似。
Serious adverse events (3%) were no more common than with placebo.
研究问题：围术期抑素治疗是否能改善行血管手术后的患者术后不良心脏事件的发生率？
Study Question: Does peri operative statin therapy improve postoperative incidence of adverse cardiac events in patients undergoing vascular surgery?
低血钾组总的严重不良事件发生率（23.8%）明显高于正常血钾组（15.8%）。
Total incidence of major adverse cardiac events in hypokalemia group(23.8%) was higher than that in normal potassium group(15.8%).
在非治疗期间不良事件发生率两组相似。
Adverse event rates during the off-treatment phase were similar between groups.
氟伐他汀治疗与不良事件发生率显著增加无关。
Fluvastatin therapy was not associated with a significant increase in the rate of adverse events.
随着肺动脉压力的升高、右心室的扩大、心功能的恶化，患者临床不良事件发生率亦大大增加。
The clinical harmful events were higher in the patients with severe pulmonary pressure and dilated right ventriculus.
结论：再灌注治疗可以降低急性ST段抬高心梗的住院死亡率，减少住院不良事件的发生。
Conclusion: Reperfusion treatment may reduce the mortality of non-ST-elevation acute coronary infarction and the incidence of events in hospital.
减少了护理差错和不良事件的发生，提高了病人满意率。
Results: It decreased nursing errors and infaust events and the satisfaction rate of patients was enhanced.
针对辖区内医疗器械不良事件报告率低的现象，结合现行的监测管理模式，查找并分析原因。
Focusing on the phenomena that the reported adverse event of medical device is quite low, we use the method to analyze the cause on the base of actual monitoring management.
安非他酮组的与药物相关的不良事件发生率为65.2%、阿米替林组为88.6%。
Incidence of adverse events was 65.2% in bupropion and 88.6% in amitriptyline.
不良事件的发生率与安慰剂组相比差异无显著意义。
There was no significant difference in the frequency of adverse event and serious laboratory abnormalities between entacapone and placebo groups.
术后6个月重复冠状动脉造影，比较两组间的晚期管腔丢失、支架再狭窄率及术后心血管不良事件发生率。
Coronary angiography was performed at the 6th month. The late lumen loss, stent restenosis and major adverse cardiac events were compared in both groups.
主要结果为全死因死亡率、心肌梗塞和不良事件。
Primary outcomes were all-cause mortality, myocardial infarction, and adverse events.
但是，强化剂量他汀疗法与较少的心血管不良事件发病率有关。
However, intensive statin therapy was associated with fewer major cardiovascular events.
各治疗组的妇科不良事件(AEs)发生率无显著差别。
There were no significant differences between treatment groups when analysing for incidence of gynaecological adverse events (AEs).
判断摄护腺癌筛检是否能降低摄护腺癌死亡率或总死亡率，并评估它对于生活品质及不良事件的影响。
To determine whether screening for prostate cancer reduces prostate cancer-specific mortality or all-cause mortality and to assess its impact on quality of life and adverse events.
结果术前持续泵入硝酸甘油及肝素能有效缓解不稳定性心绞痛，降低心血管不良事件的发生率。
Results the continuously intravenous pumping of heparin and nitroglycerin before surgery efficiently relieved unstable angina and reduced the incidence of cardiovascular events.
两组不良事件发生率的主要组成事件为需要输两个或以上单位的血液，其在夹合器组为9%，而在外科治疗组为53%。
The main driver of this adverse event rate in both arms of the study was a need for transfusion with two or more units of blood, in 9% of the clip patients and in 53% of the surgery patients.
应用多因素回归对高危因素与住院期间死亡和不良心血管事件的发生率进行分析。
Multivariate regression of risk factors and hospital mortality and the incidence of adverse cardiovascular events were analyzed.
初级终点为3个月时脱离透析。次级终点包括一年时肾脏和患者生存率以及严重的不良事件。
The primary end point was dialysis independence at 3 mo. Secondary end points included renal and patient survival at 1 yr and severe adverse event rates.
根据摄取率高低分为高摄取、低摄取和无摄取组，随访1年以上，对3组患者心脏不良事件的发生率进行比较。
All patients were divided into 3 groups by the level of 99mtc-hl91 uptake rate and followed up above 1 year, compared the incidence rate of hard events to 3 groups.
奥美沙坦组没有出现任何累及肾脏转归的不良事件。总的来看，心血管疾病的发病率和病死率很低，不足整个受试人群的1%。
No adverse events from olmesartan were observed on renal outcomes, and the incidence of cardiovascular morbidity and mortality was low overall, affecting fewer than 1% of the entire study population.
两组患者生存率和严重不良事件发生率相似。
Patient survival and severe adverse event rates were similar in both groups.
两组患者生存率和严重不良事件发生率相似。
Patient survival and severe adverse event rates were similar in both groups.
应用推荐